Ranolazine extended release is a useful adjunct in the treatment of chronic stable angina pectoris

被引：0
作者：
不详
机构：
来源：
Drugs & Therapy Perspectives | 2007年 / 23卷 / 1期
关键词：
D O I：
10.2165/00042310-200723010-00001
中图分类号：
学科分类号：
摘要：
Ranolazine extended release (ER) is indicated for the combination treatment of chronic stable angina in patients who have not achieved an adequate response with other antianginals. As add-on therapy with other antianginals, ranolazine ER improves exercise tolerance, reduces the frequency of anginal attacks and overall nitroglycerin consumption. It has an acceptable tolerability profile. © 2007 Adis Data Information BV. All rights reserved.
引用
收藏
页码：1 / 4
页数：3
相关论文
共 13 条
[1]  
Steg P.G., Stable angina: Pathophysiology, diagnosis and treatment, Am J Cardiovasc Drug, 3, SUPPL. 1, pp. 1-10, (2003)
[2]  
Gibbons R.J., Abrams J., Chatterjee K., Et al., ACC/AHA 2002 Guideline Update for the Management of Patients with Chronic Stable Angina: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina) [Online]
[3]  
Siddiqui M.A.A., Keam S.J., Ranolazine: A review of its use in chronic stable angina pectoris, Drugs, 66, 5, pp. 693-710, (2006)
[4]  
Product Information (US): Ranexa™ (Ranolazine) Extended-release Tablets 500mg
[5]  
Jan 2006 [Online]
[6]  
Jerling M., Clinical pharmacokinetics of ranolazine, Clin Pharmacokinet, 45, 5, pp. 469-491, (2006)
[7]  
Chaitman B.R., Skettino S.L., Parker J.O., Et al., Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina, J Am Coll Cardiol, 43, 8, pp. 1375-1382, (2004)
[8]  
Chaitman B.R., Pepine C.J., Parker J.O., Et al., Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trial, JAMA, 291, 3, pp. 309-316, (2004)
[9]  
Stone P.H., Gratsianski N.A., Blokhin A., Et al., Antianginal efficacy of ranolazine when added to maximal therapy with conventional therapy: The Efficacy of Ranolazine in Chronic Angina trial, Circulation, 112, SUPPL. 17, pp. 748-749, (2005)
[10]  
Timmis A.D., Chaitman B.R., Crager M., Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes, Eur Heart J, 27, 1, pp. 42-48, (2006)
12